Elevation of serum creatine phosphokinase in hospitalized patients

Khalil A Amir1, Sydney X Chen, Ravi K Bobba

  • 1Geriatrics and Palliative Care, University of Virginia Health, Charlottesville, Virginia, USA.

Insights

Patients with elevated creatine phosphokinase (CPK) levels, whether cardiac or noncardiac, face significant mortality risks. Noncardiac CPK elevations are more common and have mortality rates comparable to cardiac elevations, with age and renal issues being key predictors.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Medicine

Background:

  • Clinical characteristics and outcomes of patients with significant serum creatine phosphokinase (CPK) elevations are not well described.
  • Distinguishing between cardiac and noncardiac CPK elevations is crucial for understanding patient prognoses.

Purpose of the Study:

  • To describe the clinical characteristics and outcomes of patients with significant noncardiac and cardiac serum CPK elevations.
  • To compare the mortality rates associated with noncardiac versus cardiac CPK elevations.

Main Methods:

  • Retrospective analysis of 158 inpatients with CPK elevation >1000 IU/L.
  • Included 137 patients with CPK elevations attributed to noncardiac or cardiac etiologies.
  • Analyzed clinical characteristics and 30-day, 3-month, and 1-year all-cause mortality rates.

Main Results:

  • Noncardiac CPK (NCCPK) elevation occurred in 69% of patients, while cardiac CPK (CCPK) elevation occurred in 31%.
  • One-year mortality was 26.6% for NCCPK and 37.2% for CCPK.
  • Older age, higher blood urea nitrogen, and creatinine levels were associated with increased mortality in both groups.

Conclusions:

  • NCCPK elevation is more frequent than CCPK elevation in a veteran population.
  • One-year mortality rates for NCCPK and CCPK elevations are comparable.
  • Age and renal insufficiency are major predictors of mortality in patients with elevated CPK levels.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...